Mutations in sigma 70 transcription factor improves expression of functional eukaryotic membrane proteins in Escherichia coli by Tomatis, Pablo Emiliano et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2019
Mutations in sigma 70 transcription factor improves expression of functional
eukaryotic membrane proteins in Escherichia coli
Tomatis, Pablo Emiliano; Schütz, Marco; Umudumov, Elina; Plückthun, Andreas
Abstract: Eukaryotic integral membrane proteins (IMPs) are difficult to study due to low functional
expression levels. To investigate factors for efficient biogenesis of eukaryotic IMPs in the prokaryotic
model organism Escherichia coli, important, e.g., for isotope-labeling for NMR, we selected for E. coli
cells expressing high levels of functional G protein-coupled receptors (GPCRs) by FACS. Utilizing an
E. coli strain library with all non-essential genes systematically deleted, we unexpectedly discovered
upon whole-genome sequencing that the improved phenotype was not conferred by the deleted genes
but by various subtle alterations in the ”housekeeping” sigma 70 factor (RpoD). When analyzing effects
of the rpoD mutations at the transcriptome level we found that toxic effects incurred on wild-type E.
coli during receptor expression were diminished by two independent and synergistic effects: a slower
but longer-lasting GPCR biosynthesis and an optimized transcriptional pattern, augmenting growth and
expression at low temperature, setting the basis for further bacterial strain engineering.
DOI: https://doi.org/10.1038/s41598-019-39492-9
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-174016
Journal Article
Published Version
 
 
The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Tomatis, Pablo Emiliano; Schütz, Marco; Umudumov, Elina; Plückthun, Andreas (2019). Mutations
in sigma 70 transcription factor improves expression of functional eukaryotic membrane proteins in Es-
cherichia coli. Scientific Reports, 9(1):2483.
DOI: https://doi.org/10.1038/s41598-019-39492-9
1Scientific RepoRts |          (2019) 9:2483  | https://doi.org/10.1038/s41598-019-39492-9
www.nature.com/scientificreports
Mutations in sigma 70 transcription 
factor improves expression of 
functional eukaryotic membrane 
proteins in Escherichia coli
Pablo Emiliano tomatis  1,2, Marco Schütz1,3, Elina Umudumov1,4 & Andreas Plückthun  1
Eukaryotic integral membrane proteins (IMPs) are difficult to study due to low functional expression 
levels. To investigate factors for efficient biogenesis of eukaryotic IMPs in the prokaryotic model 
organism Escherichia coli, important, e.g., for isotope-labeling for NMR, we selected for E. coli cells 
expressing high levels of functional G protein-coupled receptors (GPCRs) by FACS. Utilizing an E. coli 
strain library with all non-essential genes systematically deleted, we unexpectedly discovered upon 
whole-genome sequencing that the improved phenotype was not conferred by the deleted genes but 
by various subtle alterations in the “housekeeping” sigma 70 factor (RpoD). When analyzing effects of 
the rpoD mutations at the transcriptome level we found that toxic effects incurred on wild-type E. coli 
during receptor expression were diminished by two independent and synergistic effects: a slower but 
longer-lasting GPCR biosynthesis and an optimized transcriptional pattern, augmenting growth and 
expression at low temperature, setting the basis for further bacterial strain engineering.
Integral membrane proteins (IMPs) have many vital biological functions, constituting approximately one third 
of all proteins in humans as well as being the targets of nearly 60% of all FDA-approved drugs1,2. Despite their 
importance, structural and functional information for IMPs is still limited. Up to now, fewer than 4% of the 
unique structures in the protein database (PDB) correspond to membrane proteins, and even fewer are of eukar-
yotic origin. For many of them, in particular for G protein-coupled receptors (GPCRs), there are no homologs 
from prokaryotes. GPCRs, the biggest IMP family, constitute almost 5% of the entire protein-coding human 
genome and are the most important class of drug targets.
Apart from a few exceptions, most IMPs have an extremely low natural abundance. Thus, they need to be 
overexpressed in heterologous hosts for detailed investigations2–4. Next to microbial hosts, such as Escherichia 
coli, Lactococcus or different yeast species (e.g., Pichia pastoris and Saccharomyces cerevisiae), researchers have 
been using mammalian cell cultures, insect cells, or cell-free systems for heterologous expression of IMPs, each 
with various degrees of success4–6. E. coli is a particularly attractive expression host because of its cost-effective 
cultivation and fast growth and especially its ability to produce isotope-labeled protein for NMR studies7 and 
rapid protein engineering approaches, by rational and combinatorial means.
Since many IMPs are very unstable when solubilized in detergents, different approaches based on either 
rational design4,8 or random mutagenesis and screening9 were used to obtain better expressing and more stable 
variants of IMPs. With the goal to improve heterologous expression of GPCRs and to create receptor variants 
with increased stability, our lab has developed several directed evolution strategies in E. coli and yeast10–14. In the 
present study, however, we focus on the bacterial host itself.
In most cases, eukaryotic hosts tolerate the heterologous overexpression of IMPs better than bacteria. While 
bacteria are able to produce some of their endogenous membrane proteins in high abundance, many IMPs, 
especially those of eukaryotic origin, are very toxic for the bacterial cell when overexpressed. Since polypeptide 
elongation is significantly slower in eukaryotes than in prokaryotes4, the overexpression of eukaryotic IMPs in 
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bacteria may cause mistargeting and misfolding not only of the IMP itself, but also of other proteins, leading to 
high cellular stress. Furthermore, the titration of the Sec translocon, the limited availability of other endogenous 
factors assisting in the biogenesis of membrane proteins, or differences in membrane bilayer properties and mem-
brane space can all affect insertion, folding and functioning of heterologous IMPs15,16.
In this study, we aimed to improve our understanding of heterologous expression of IMPs in E. coli, which 
would potentially allow the generation of bacterial expression strains that are more tolerant to the overexpression 
of eukaryotic IMPs. While for crystallography and electron microscopy, protein production can be carried out 
in insect cells or mammalian cells, for NMR, the facile preparation of isotope-labeled IMPs in E. coli would be a 
great advantage.
We planned to elucidate the bottlenecks of eukaryotic IMP biogenesis in bacteria with an unbiased approach, 
not limiting ourselves to a particular pathway, using pharmacologically relevant GPCRs as a model system. It 
was our aim to solve this problem not only practically, but also to make a contribution to elucidating the mech-
anism. Currently, the knowledge of the basic cellular processes that govern the biogenesis of heterologous IMPs 
in bacteria remains incomplete, and a systematic characterization of bacterial genes involved in this process as 
well as possible epistatic genetic interactions between them is still lacking. It seems intuitive that all steps during 
the biogenesis of a membrane protein need to be extremely well coordinated and balanced17. As a consequence, a 
rational approach to improve an IMP protein production system that finally would lead to higher levels of func-
tionally expressed IMPs would be very difficult.
For this reason, we used a methodology previously developed in our laboratory that allows the detection of 
functional IMPs in E. coli at the single cell level by using fluorescent ligands and FACS, thus being able to select 
individual cells with improved functional expression level. As a model system, we used GPCRs to be expressed 
in E. coli. Our approach finally led to the discovery that a specifically mutated sigma factor has favorable effects 
at this process at several levels.
Results
Selection from the Keio collection for improved GPCR expression. Selection. In order to iden-
tify E. coli genes that could affect the heterologous production of GPCRs, we used a selection strategy based on 
fluorescence-activated cell sorting (FACS) developed in our laboratory that allows the isolation of cells showing 
increased expression levels of functional receptors that bind to a fluorescent ligand10–12. We screened a systemat-
ically constructed E. coli strain library consisting of clones, each with a precisely defined single-gene deletion in 
the genome, the so-called Keio collection18. We searched for E. coli strains showing increased functional expres-
sion of the rather unstable wild-type rat neurotensin 1 receptor (NTR1), which puts a significant stress on the 
host10.
The pooled Keio collection, consisting of 3985 different strains, was transformed with an expression vec-
tor denoted as pRG-NTR, encoding NTR110. The transformation efficiency was 3 × 106 cfu, well 100-fold above 
the library size to ensure exhaustive representation, giving rise to the E. coli strain library termed Keio-NTR1. 
After expression of NTR1 at 20 °C, permeabilization of the outer membrane and incubation of the cells with a 
fluorescently-labeled neurotensin ligand allowed it to bind to the functional receptor in the inner membrane of 
E. coli as previously described10. Subsequently, the most fluorescent cells, which consequently exhibit the highest 
expression levels of functional receptor, were isolated with FACS (Fig. S1).
After six iterative selection rounds, we could not detect an improvement of the expression level within the 
strain library expressing NTR1 (Fig. S2), as under these conditions of limited growth the fluorescence signal was 
similar between the pool of the selected E. coli deletion clones compared to the corresponding wild-type E. coli 
strain. However, we noticed variations in the fluorescence signal within experiments for some tested strains, so 
if the upshift of the fluorescence signal in the sorted clones is small and counterbalanced by strains in the pool 
with decreased receptor expression, a positive effect in the signal may go undetected. Therefore, we decided to 
investigate whether the selections may still have resulted in an enrichment of certain Keio clones over others, e.g., 
because the enriched clones may tolerate the expression of NTR1 better than the wild-type strain and may thus 
harbor favorable properties.
Identification and characterization of selected strains. The identification by inverse PCR of the selected E. coli 
Keio strains revealed that five specific clones from the Keio collection had indeed become enriched (Fig. S3). 
Intriguingly, there was no obvious direct relationship of the function of the genes that are deleted on these 
enriched clones with known pathways of membrane protein biosynthesis.
These five enriched strains from the selection were picked again from the original Keio collection, thus not 
harboring any plasmid, for further analysis. A characterization of the growth behavior in rich medium (2 × YT 
medium) in comparison to the control strain BW25113, from which the Keio library was derived, showed that the 
growth rates and the final cell density after 20 hours of cultivation at 37 °C were identical. On the other hand, the 
final cell density reached after 20 hours of cultivation at 20 °C was higher for 4 of 5 clones (Fig. S4), even though 
their growth rates at 20 °C were equivalent.
These Keio E. coli strains as well as the control strain BW25113 were then freshly transformed with the vector 
pRG-NTR. The presence of the corresponding gene deletions in the freshly transformed strains was verified by 
iPCR and sequencing.
Following identical culture conditions and protocol for receptor expression as in the selection procedure, we 
found that the same selected Keio strains (ΔybaA, ΔqseB, ΔhybD and ΔuxuB) expressing NTR1 can also reach a 
higher final cell density after 20 hours at 20 °C, in comparison to the wt E. coli strain BW25113 (Fig. 1), all having 
the same growth rates. At 20 °C, the optimal temperature for functional receptor expression and selection, the 
overexpression of GPCRs is not quite as stressful for the cells as at 37 °C10, and apparently these Keio strains can 
grow for a more extended duration than the strain BW25113.
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As expected from previous experiments, expression of the GPCRs is clearly toxic for the host, as the untrans-
formed strains (without NTR1 expressed) reach higher cell densities than with NTR1 (Figs 1 and S4).
We then investigated whether the production of functional receptors was affected in addition to the improved 
growth behavior discovered. Indeed, although GPCR expression measurements are usually noisy, a statistically 
significant increase in functional receptors/cell was found for NTR1 measured by radioligand binding assays 
(RLBA) in the selected Keio clones ΔqseB, ΔhybD and ΔuxuB (Fig. 1).
No genotype - phenotype link with Keio deletions. In order to check our findings, we re-constructed 
by recombineering19 the equivalent single-gene deletion clones from the Keio collection in the same genetic back-
ground of the control strain BW25113.
Unexpectedly, the growth and receptor levels in these newly made deletion strains were as in the control 
strain. Thus, there seems to be no direct correlation between the deleted genes and the observed phenotype of 
improved GPCR expression.
While the enrichment of the original Keio clones (ΔhybD, ΔqseB, ΔybaA and ΔuxuB) was reproducible, 
as were their phenotypes regarding resistance to GPCR expression stress, it appeared that these properties were 
not related to the presumed genotypes denoted in the Keio collection, but still somehow linked to the particular 
strains.
Identification of causative mutation by whole genome sequencing. To identify the genetic mod-
ification that causes the difference in the observed phenotype, the DNA sequence of the whole genome of the 
most promising selected Keio clone (ΔqseB) and the wild-type strain BW25113 were determined. The obtained 
genome sequence of BW25113 is in agreement with a sequence deposited afterwards (GenBank accession num-
ber CP009273)20.
In the ΔqseB Keio clone, a non-silent single nucleotide substitution in the rpoD gene was identified and 
confirmed by Sanger sequencing. This essential gene encodes the sigma 70 subunit of the RNA polymerase, the 
primary sigma factor during exponential growth, which targets RNA polymerase to the majority of promoters 
operative under normal growth conditions21. The nucleotide change in the rpoD gene results in a valine instead 
of glutamate in amino acid position 575 (domain 4.2) of the sigma 70 transcription factor (Fig. 2). This position 
plays an important role in the interaction between RNA polymerase and promoters22 (Fig. 2).
Recreating new E. coli strains with and without the rpoD mutation. To confirm the correlation 
of this mutation with the observed phenotype we wanted to create a new E. coli strain carrying only the muta-
tion rpoD-E575V. For this purpose, a site-directed genome mutagenesis approach based on recombineering was 
developed (detailed in Supplementary Information: Supplementary Methods). Briefly, we created two DNA frag-
ments comprising the kanamycin resistance cassette targeted to the mug gene, downstream of rpoD (encoding 
the non-essential mismatch-specific uracil DNA-glycosylase) and the last 350 bp of the rpoD gene with the E575V 
mutation or, alternatively, with the wild-type sequence (Fig. S5). Using recombineering19 we thus generated two 
new E. coli strains: BW25113 rpoD-E575V Δmug::Km (abbreviated rpoD* from now on) and the control strain 
BW25113 wt rpoD(E575) Δmug::Km, which is rpoD wt (Fig. S5). These two newly constructed strains thus differ 
only by the E575V mutation in rpoD.
Figure 1. Expression of NTR1 receptor in the selected E. coli strains from the Keio collection. E. coli strain 
BW25113 (WT) and the most abundant clones of the selected Keio clones were transformed with the plasmid 
pRG-NTR. Expressions of NTR1 receptor are as described in Materials and Methods. The x-axis label indicates 
the gene that is deleted on the respective Keio clone. Means and Standard Deviations from three independent 
experiments are shown. (a) Growth was estimated with OD600nm measurements after 20 hours of GPCR 
expression at 20 °C. Strains with statistically significant increases in growth versus wild-type E. coli BW25113 
are calculated by two-tailed paired t test; p values are indicated. (b) Receptor expression levels were assessed by 
radioligand binding assays. The y-axis represents the number of functional receptors per cell, averaged across 
an entire population of cells. Statistical p values, as calculated by two-tailed paired t test, are indicated for strains 
with statistically significant increases in receptors per cell versus wild-type E. coli BW25113.
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Using these newly generated strains, we performed receptor expression experiments. Both the final cell den-
sity after expression and the functional receptor number per cell, estimated with RLBA, demonstrated that the 
improved phenotype displayed by the Keio clone ΔqseB is fully recapitulated and thus only due to this single 
point mutation E575V in rpoD (Fig. 3).
Influence of medium. In all previous experiments, growth of the different bacterial strains was performed 
in the complex rich medium 2 × YT. In order to test the influence of the culture medium, we also investigated 
Figure 2. Structural interactions of sigma 70 factor in the RNA polymerase transcription initiation complex 
and location of selected mutations. (a) Domain organization, conserved regions and promoter recognition of 
the sigma 70 factor (green). Interactions between sigma 70 and DNA are depicted with dashed lines. The non-
template DNA strand is colored magenta and the template strand cyan, with key consensus promoter elements 
contacted by sigma 70 (light green) indicated in pink with letters. Transcription initiates at +1. Mutations found 
in the rpoD gene in this work are highlighted in red. Adapted from65. (b) Overall structure and organization of 
E. coli sigma 70 in the RNA polymerase transcription initiation complex based on PDB ID: 4YLN39. Sigma 70 
(surface representation) and promoter DNA (cartoon) are colored as above. Inset zooms show the HTH domain 
of sigma 70 where the mutation E575V is located, and interaction of mutations in sigma 70 domain 2 with 
DNA. Adapted from65.
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the EnPresso B system from BioSilta23. In this system glucose is enzymatically liberated from a polysaccharide 
substrate in a slow reaction. By this slow glucose-feeding, production of growth-inhibiting acids by the bacteria 
is reduced. Furthermore, the medium provides minerals, vitamins, and trace elements. As a result of these opti-
mized medium conditions, higher cell densities can be reached with the EnPresso B system. Interestingly, we 
found that using the previously described protocol for receptor expression but using this optimized medium, the 
rpoD* strain can still reach double the cell density of the control strain when expressing wild-type NTR1 at 20 °C 
for 20 hours (Fig. S6a). Under these conditions, the newly developed rpoD* strain also produces more functional 
receptors per cell than the control strain (Fig. S6b).
Furthermore, we decided to also test the growth properties of the E. coli strains in minimal medium, as this 
would be important for future isotope labeling experiments. The selected Keio clones grew also to higher cell 
densities during expression of wild-type NTR1 at 20 °C (Fig. S7).
Genetic background of other Keio clones. The rpoD-E575V mutation was found in the Keio clone 
ΔqseB, which had been enriched after iterative rounds of expression and selection using FACS from the Keio 
library transformed with an expression vector encoding wild-type NTR1. We verified by PCR of the genomic 
DNA and subsequent Sanger sequencing that this single point mutation was already present in the original Keio 
clone ΔqseB from the collection. However, we did not find the rpoD-E575V mutation in the other enriched 
clones, nor in wild-type BW25113.
We were thus interested to elucidate which mutations the other enriched clones from the Keio collection 
(ΔhybD, ΔybaA, and ΔuxuB) might carry, as they confer a similar phenotype. For this reason we also charac-
terized them by whole genome sequencing. We found that all the three clones also have alterations exclusively 
in the sigma 70 factor gene rpoD: Keio strain ΔhybD has a deletion of 16 amino acids from position 172 to 187 
(172|EDLAPTATHVGSELSQ); ΔuxuB carries the mutation I141S and ΔybaA the mutation D213Y (Fig. 2).
Other GPCRs. With the intention to test whether the observed phenotypes in the selected Keio clones are 
also obtained when other wild-type and hard to express GPCRs are expressed, we used the original Keio clones 
(ΔhybD, ΔqseB, ΔybaA and ΔuxuB) and transformed the strains with plasmid derivatives of pRG expressing 
alpha-1b adrenergic receptor (ADRA1b), tachykinin receptor (TACR), or μ-opioid receptor (MOR). Consistent 
with the previous results, these Keio collection clones also grow to significantly higher density than the wild-type 
control strain E. coli BW25113 when expressing TACR. For ADRA1b and TACR, Keio clones ΔqseB and to a 
lesser extent ΔuxuB can grow better during receptor expression (Fig. 4).
Introducing the rpoD mutation into E. coli BL21. In order to prove that the point mutation in rpoD can 
also have an effect in a different genetic background, we generated a rpoD-E575V mutant of the BL21 Tuner strain 
which is frequently used for protein expression24. Indeed, the NTR1 expression experiments confirmed that the 
single point mutation E575V in rpoD also improved the growth and receptor yield in BL21 Tuner (Fig. S8), albeit 
to a somewhat smaller extent than in the BW25113 background. Comparable results were found when different 
GPCRs (ADRA1b, TACR and MOR) were analyzed (Fig. S9).
Gene expression. The mutation E575V found in the sigma factor gene rpoD (Fig. 2) may have a role in 
the specific interaction between RNA polymerase and promoters during transcriptional activation. The receptor 
genes in the pRG vector are under control of the lac promoter, and thus regulated by sigma 70. Therefore, it is 
Figure 3. Expression of NTR1 in different strains. E. coli BW25113 (WT), Keio clones and the newly created 
strains were transformed with the plasmid pRG-NTR. (a) Growth was estimated with OD600nm measurements 
after 20 hours of NTR1 expression at 20 °C. (b) Receptor expression levels were assessed by radioligand binding 
assays. Means and standard deviations from three independent experiments are shown.
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possible that this single point mutation modifies the mRNA levels in the bacteria, in particular the mRNA of the 
GPCR itself being expressed from the plasmid, but also that of other proteins.
qPCR. In order to test this hypothesis, we initially attempted to quantitate the relative mRNA amount of the 
NTR1 gene by using real-time qPCR. Different genes were tested as reference genes that had been suggested 
before as being constitutively expressed, for obtaining a relative quantification of NTR1: ihfB25; cysG, hcaT, and 
idnT26; and some genes suggested by the software Genevestigator from RefGenes27. Unfortunately, none of those 
fulfilled the requirements for a suitable reference gene under the tested conditions, as they were found themselves 
variable. Since the mutation in the sigma factor can have a broad and general impact on the expression of many 
genes, it may be unavoidable that it affects the potential reference genes as well.
Spike in. We thus used an exogenous RNA as a reference28, the Universal RNA Spike II (TATAA Biocenter). 
This allowed us also to test for inhibition of the enzymatic reactions inherent in amplification and estimate the 
RNA extraction yield. All samples taken from strains E. coli BW25113 wt (pRG-NTR) and E. coli BW25113 rpoD* 
(pRG-NTR) exhibited nearly identical Ct values (ΔCt < 0.2) for RNA Spike II.
Hence, using the RNA Spike II as a reference, we were able to determine that the expression of the NTR1 gene 
is down-regulated (log2 ratio = −2) in the rpoD* strain. Next, we also compared the expression of the NTR1 gene 
in the other Keio clones with mutations in rpoD gene (ΔhybD, ΔybaA and ΔuxuB). All the strains showed that 
NTR1 is down-regulated (log2 ratio near to −2) (Fig. S10).
RNA-seq. The mutation in rpoD may have, in addition to its direct effect on the GPCR gene, a more general 
effect on the expression of many genes. Therefore, we performed a whole transcriptome analysis (RNA-seq) of 
the E. coli strains under study, in order to find differentially expressed genes in a global and unbiased approach.
We prepared total RNA from the bacterial strains E. coli BW25113 wt and BW25113 rpoD*, both with and 
without the expression plasmid pRG-NTR, encoding the wt NTR1. Samples for RNA extraction were taken after 
4 hours at 20 °C for NTR1 expression (when present). RNA-seq and the bioinformatics analysis were carried out 
as detailed in Supplementary Methods.
After quality control and processing, an average of 17 million reads and 94% of genomic features with reads 
above the threshold could be analyzed. To identify differentially expressed genes, we used a combined threshold 
of p-value (<0.01), fold-change >2 (log2ratio >1 or <−1) and at least 10 counts (for details, see Supplementary 
Methods)
A full set of gene expression data is shown in Table S1 and a summary of the number of up- and 
down-regulated genes found is shown in Table S2. A direct comparison of NTR1 expression in the wild-type 
strain versus the mutant strains shows that the level of receptor expression is lower in the mutant strain with a log2 
ratio = −0.28, consistent with the qPCR data, albeit with a p-value of 0.068.
Table 1 shows a summary of the functional analysis of differentially expressed genes.
The rpoD-E575V mutation changes the expression levels of several genes in the E. coli BW25113 background, 
mainly by down-regulation (Fig. S11). Most genes under control of sigma factor 38, degradation pathways (amino 
acids, fatty acids and lipids, amines and carbohydrates), response to osmotic stress and starvation-related genes 
are down-regulated. On the other hand, pathways by which glycerol can be degraded to serve as a source of car-
bon and energy, as well as genes coding for plasma membrane components are up-regulated (Fig. S11).
When analyzing the effect of expressing NTR1 wt in the wt E. coli strain vs. the strain alone, we observed that 
receptor overexpression leads to an up-regulation of genes related to generation of energy, mainly anaerobic res-
piration, suggesting that receptor overexpression interferes with oxidative phosphorylation (Fig. S11). More genes 
controlled by sigma factor 32 (heat shock stress response), sigma 54 (nitrogen metabolism) and sigma 38 (general 
Figure 4. Cell growth after 20 h of GPCRs expression in different Keio clones. E. coli BW25113 (WT) and 
selected Keio clones were transformed with pRG plasmid derivatives encoding the wild-type version of 
ADRA1b, TACR1 and MOR GPCRs. Growth was estimated with OD600nm measurement after 20 hours of GPCR 
expression at 20 °C. The x-axis label indicates the gene that is deleted in the respective Keio clone. Means and 
standard deviations from three independent experiments are shown. Statistical p values, as calculated by two-
tailed paired t test, are indicated for strains with statistically significant increases in growth versus wild-type E. 
coli BW25113.
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stress) are up-regulated than down-regulated, while sigma factor 28 dependent genes (motility and flagella) are 
largely down-regulated (Table S3). Also, transporter genes and those that are involved in protein type III secretion 
are significantly down-regulated, as well as plasma membrane components and lipopolysaccharide metabolism 
proteins (Fig. S11).
When genes are ordered by their log2 ratio according to the influence of expressing NTR1 in the E. coli 
wt, almost the mirror image is found when comparing E. coli wt and the rpoD mutant, both expressing NTR: 
the rpoD* mutation brings the physiology of E. coli back to where it was without expressing the GPCR NTR1 
(Fig. S12). Most of the differentially expressed genes that are up-regulated when NTR1 is produced in the wt E. 
coli strain vs. the strain alone have lower expression values when the receptor is expressed in the mutant rpoD 
strain and vice versa (Table 1).
Time course of NTR1 accumulation. In order to obtain a better understanding of NTR1 expression kinet-
ics and whether the rpoD* mutation may influence it, cell samples of the wt and rpoD* mutant strains were taken 
as a function of time after induction of protein expression at 20 °C. At the same time, equivalent aliquots were 
used to estimate cell number (by measurement of optical density at 600 nm), functional receptors per cell (by 
RLBA), NTR1 gene expression (by qPCR) and total NTR1 protein amount by Western blot (Fig. 5).
The NTR1 gene expression rate is lower in the rpoD* strain over the whole time of receptor production. 
However, after approximately 4 hours of induction, the level of functional receptor in the wt strain seems to reach 
a plateau. In contrast, in the rpoD* mutant strain the level of functional NTR1 keeps increasing until 20 hours 
after protein induction. In parallel, cell growth in the wt strain has almost stopped after 5 hours, while the mutant 
strain continues to grow until the end of the experiment. Therefore, although the protein expression rate in the 
mutant E. coli strain is lower during the first hours, at later times it is still producing functional NTR1 protein, 
thereby reaching a higher level overall.
Discussion
Overexpression of eukaryotic IMPs such as GPCRs in bacteria is usually toxic for the host. IMP toxic-
ity is presumed to be due mainly to the overloading of the Sec translocon machinery29, which handles both 
the post-translational export of periplasmic proteins (via the SecB chaperone-targeting pathway) and the 
co-translational insertion (via the signal recognition particle (SRP)-targeting pathway) of most IMPs into the 
lipid bilayer membrane30. The translocation of proteins is hindered when the Sec translocon is saturated, possibly 
because of slow transport of heterologous membrane proteins and/or because of remaining interactions with the 
pore. Other toxic effects due to IMP expression include the accumulation of cytoplasmic protein aggregates and 
reduction of the levels of respiratory chain complexes in the bacterial membrane, which results in inefficient ATP 
production31.
Our aim was to investigate how E. coli cells could adapt to the stress of producing a toxic IMP and we wished 
to identify E. coli genes with an influence on GPCR expression. While our approach intended, in a first screen, 
to elucidate the effect of single gene deletions using the Keio collection (clean individual deletions of all nones-
sential genes of E. coli18), our study ultimately identified point mutations in the sigma factor 70, the rpoD gene, 
as responsible for a phenotype with significantly improved GPCR expression. The phenotypes of the enriched 
Strain E. coli rpoD vs. E. coli wt E. coli wt (NTR) vs. E. coli wt E. coli rpoD (NTR) vs. E. coli wt (NTR)
UP
Glycerol degradation Anaerobic respiration Flagella - Sigma 28 regulon - FlhDC
Plasma membrane proteins
Nitrate Reduction CysB regulon
Fermentation Glycerol metabolism
Glycolysis Iron homeostasis (Sigma 19)
Glycerol degradation Sigma 70 regulon
Electron Transfer
Transcription factor regulons: Crp, 
Cra, IHF, Nar, Fis, ArcA, Fnr
Sigma 38 regulon
Sigma 54 regulon
Sigma 32 regulon
DOWN
Sigma 38 regulon Flagella - Sigma 28 regulon - FlhDC Anaerobic respiration
Osmotic Stress Plasma membrane proteins Electron Transfer
Starvation Response to cold Nitrate reduction
Degradation of: amino acid, lipids, 
amines and carbohydrates
Protein secretion Transcription factor regulons: Crp, Fnr, Cra, Fis, IHF, Nar, ArcA
Arginine degradation Sigma 38 regulon
Lipopolysaccharide Metabolism 
Proteins Sigma 32 regulon, protein folding chaperones
Table 1. Summary of gene enrichment analyses from RNA-seq data. Compiled data of the enrichment analyses 
of the gene-expression from SmartTables and Omics Dashboard from BioCyc.org and the sigma factors dataset 
from RegulonDB analyzed with the Fisher exact statistics algorithm.
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strains appeared indeed favorable for expressing wild-type GPCRs, essentially overcoming the stress imposed by 
the GPCR expression. From this point of view the selection has been very successful, but the mechanism was a 
different one than initially expected.
The point mutation E575V in the rpoD gene was found to be already existent in the original Keio clone ΔqseB 
from the collection. Other selected strains also turned out to have other mutations in the rpoD gene, with a 
less pronounced phenotype. The spontaneous mutation rate for E. coli has been estimated to be approximately 
1 × 10−3 per genome per generation for cells cultured under standard laboratory conditions32. However, it should 
be noted that the spontaneous mutation rate is stress-dependent33. It is thus plausible that stress during the con-
struction of the Keio strain collection could be the reason of the genetic instability of the E. coli BW25113 parent 
strain34, which has allowed the rpoD mutations to occur.
Bacteria control transcription initiation rates through regulation of sigma factor activity, a bacterial transcrip-
tion initiation factor that enables specific binding of RNA polymerase to gene promoters. The sigma factor 70 (the 
rpoD gene product) is responsible for transcription of most genes expressed during the exponential cell growth35. 
Besides sigma 70, six other molecular species of alternative sigma factors in E. coli have been identified, present 
in the cell at different levels35,36. The accumulation of non-native or foreign structures in a membrane can induce 
stress responses and activate proteolytic systems of the overexpression host. Cells then produce stress-responsive 
proteins to alleviate the impact of the overexpressed protein and readjust their metabolism, predominantly via 
the heat-shock response of sigma 32 and sigma 24 pathways37, which compete with sigma 70 for the RNA pol-
ymerase core subunits. Mutations in sigma 70 may therefore not only affect the transcription initiation rates of 
corresponding promoters but also shift the balance between the other sigma factors.
The amino acid change Glu575 to Val in rpoD, leading to the most effective phenotype, lies in the first helix 
of the helix-turn-helix (HTH) motif in the carboxyl-terminal region of sigma 70 (Fig. 2). When we created the 
rpoD-E575V mutant in E. coli BL21(DE3) we found that the phenotype is also improved, albeit by a slightly lower 
amount. The reason for this smaller alteration may be that there is already a single amino acid difference in the 
rpoD wild-type gene between the BW25113 and BL21 strains in position 571, where BW25113 has E571, while 
BL21 and most of the E. coli strains carry H571.
Various mutations in the rpoD gene have been observed which affect transcription initiation that can be 
rationalized on the basis of the RNAP holoenzyme structure38,39. Jishage et al.40 reported that mutations such as 
rpoD-ΔDSA (536–538) and rpoD-Y571H have a reduced ability to bind to the RNA polymerase core and, for this 
Figure 5. Kinetics of NTR1 expression. E. coli BW25113 (wt) and the rpoD E757V mutant strain were 
transformed with the plasmid pRG-NTR. NTR1 expression at 20 °C was performed for 20 hours. Samples were 
taken at different time points. (a) Growth was monitored with OD600nm measurements. (b) Functional receptor 
levels were estimated by radioligand binding assays. (c) mRNA NTR1 levels were calculated by quantitative real-
time PCR and expressed as log2 ratios between rpoD mutant vs. wt E. coli strain. (d) NTR1 protein levels were 
monitored with western blots using an anti-MBP antibody (in duplicates). The blot image has been cropped for 
conciseness. The band intensity data are not quantitative. The full-size blot is presented in Fig. S13.
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reason, reduce their capability to compete for the core enzyme with the other sigma factors. These mutations have 
thus a similar consequence to that of Sigma 70 underproduction, or instead overproduction of the anti-sigma-70 
factor Rsd40.
Several other examples of rpoD mutations have been described: some substitutions significantly decreased 
ada-dependent transcription, with rpoD E575V having the most severe effect, although the Glu-575 residue 
does not seem to be necessary for activator-independent transcription41; rpoD-E575A can reduce uhpT expres-
sion depending on the genetic background42; rpoD-R596, which increases expression of the ara regulon43; and 
rpoD-E575K which increases lac promoter activity44, while pho promoters are then less expressed45. Many of the 
rpoD mutations that were selected to alter the promoter recognition properties of RNA polymerase are in or near 
a conserved region of sigma 70 denoted as the helix-turn-helix motif (Fig. 2)46. Also, truncated rpoD mutants 
resulted in an increased ethanol tolerance in E. coli, due to a higher binding affinity of the truncated mutants to 
anti-sigma factors, relative to that of the full-length sigma 70 factor47. Additionally, in a study of laboratory evolu-
tion of pathway-engineered E. coli that under-produces the redox cofactor NADPH on glucose, the rpoD-D213Y 
discovered in our work was also found during their screening, although the authors did not provide details48. 
Collectively, these and our novel results underline that subtle changes in sigma 70, despite influencing a very gen-
eral prokaryotic transcription factor, can change the relative individual expression levels of genes differentially.
We found that the GPCR gene is expressed at a lower rate in the rpoD* mutant E. coli strain when induced 
from the lac promoter, but that expression and cell growth both continue for a longer time, leading at the end 
to a 4-fold higher receptor yield per culture volume. This slower rate of biosynthesis seems to diminish the toxic 
effects of receptor expression. The simplest interpretation would be that all these mutations in the sigma 70 tran-
scription factor reduce — directly or indirectly — the affinity of the RNA polymerase to the promoter, so that the 
transcriptional initiation frequency is lowered. This would lead to a slower but longer-lasting mRNA and GPCR 
production, less toxicity for the cell permitting longer cell growth, ultimately leading to higher GPCR expression 
levels.
This rpoD* effect is indeed seen for growth at 20 °C: GPCR expression at 37 °C causes a particularly high 
stress and is so toxic that even reducing the kinetics of expression is insufficient to make a significant difference in 
functional receptor expression. Interestingly, the bacteria with the rpoD* mutation can grow better and longer at 
20 °C — independent of GPCR expression — even though the difference is not as pronounced as when overcom-
ing stress through GPCR expression. This underlines the notion that the rpoD mutations must have additional 
beneficial effects for the cell at 20 °C by affecting other genes.
Whole transcriptome data of the E. coli strains were analyzed to study the effect of the stress-induced by GPCR 
overexpression and the effect of the selected rpoD mutations to dampen the effect on the cellular stress (Table S1). 
In either case, the observed up- or down-regulation of genes may be indirect, and not directly be under the con-
trol of the sigma factor under study.
Work from the de Gier group31,49 has shown the consequences of prokaryotic and eukaryotic membrane pro-
tein overexpression in E. coli at the protein level. Our transcriptome data described here for expression of NTR1 
in the E. coli strain BW25113 have many correspondences with the proteomics data previously reported. We 
have likewise found up-regulated genes under the control of sigma 32 (heat shock response during log-phase 
growth), such as chaperones DnaK, IbpA, ClpB, GroELS, and the protease components HslVU; the activation 
of the Arc two-component system; the levels of enzymes involved in glycolysis (GapA, Pgk, Gpm, PykF) and in 
fermentation; as well as genes related to anaerobic respiration (Tables 1 and S1). In contrast, we find that sigma 
24-dependent genes are both among the up- and down-regulated ones.
Although below the defined statistical cutoff, we detected increased levels of SecA, and found that some 
secreted proteins, like UgpB, TreA and ArgT, show a significantly decreased expression upon GPCR overexpres-
sion (Table S1). In addition, in our study the type III protein secretion system complex is down-regulated. All 
these observations suggest that the Sec translocon-mediated translocation of secretory proteins across the cyto-
plasmic membrane is also impaired upon NTR1 overexpression, potentially having an impact in the membrane 
protein composition, including the respiratory machinery. We likewise observed that the Arc two-component 
system response (redox sensor) and the phage shock protein A (PspA) response is activated upon receptor expres-
sion, consistent with cell envelope stress (Table S1).
Taken together, the consequences of overexpression of NTR1 in the E. coli strain BW25113 are similar to 
those of the overexpression of prokaryotic and other eukaryotic membrane proteins in other E. coli strains such 
as BL21(DE3)pLysS, C41(DE3) and C43(DE3) strains49.
In line with our findings, Link et al.50 demonstrated that overexpression of either FtsH or the cannabinoid 
receptor CB1, another GPCR, leads to induction of the heat-shock (sigma 32) stress responses. On the other 
hand, genes corresponding to the regulons of sigma 54 (nitrogen limitation), sigma 38 (general stress/ stationary 
phase) and sigma 28 (flagella synthesis) did not exhibit any noticeable variation upon expression of either CB1 
or FtsH50.
The effect of the rpoD-E575V mutation when E. coli is grown at 20 °C (without NTR1 expression) can be 
rationalized in terms of what is known about bacterial adaptation to cold temperatures. E. coli exposed to a tem-
perature decrease responds via cold-shock proteins termed Csps (mainly nucleic acid chaperones), increasing 
membrane fluidity (LpxP acyltransferase) and expression of stress-related genes controlled by sigma factor 38 
(RpoS)51. White-Ziegler et al.52 reported that almost half of the genes up-regulated at 23 °C compared with those 
at 37 °C were controlled by sigma factor38. Interestingly, our transcriptome analysis indicates that most of those 
genes related to cold shock response are down-regulated in the rpoD mutant strain compared to the wt E. coli 
strain upon growth at 20 °C (Tables 1 and S1). This can be interpreted as the rpoD mutation allowing better adap-
tation to growth at lowers temperatures, and that these additional cold shock responses are less essential.
It thus appears that the selection of a mutation in rpoD may have two independent beneficial effects; first, a 
decrease in expression rate of the toxic GPCR itself and second, a “renormalization” of the genes from the stress 
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phenotype to one of normally growing E. coli (Fig. S11). While part of this effect can be indirect, i.e., by decreasing 
the stress in a cell that produces the receptor more slowly, we would like to reiterate that the rpoD* strain also has 
improved growth properties at low temperature in the absence of GPCR expression.
It is probably for this dual role why the rpoD mutations appear to have an additional benefit over the straight-
forward lowering of expression rate by low inducer level, the use of different (weaker) promoters or the use of low 
copy number plasmids.
A general picture thus emerges in that the NTR1 expression rate from the plasmid pRG-NRT1 in the rpoD* 
mutant strain is always lower than in the wt. However, the level of functional receptor and the cell growth stopped 
after 4 hours of production in the wt strain. In contrast, the mutant strain continued to grow without problems 
and kept on synthetizing functional NTR1 for at least 20 hours after induction. Therefore, the final functional 
GPCR yields are increased in the rpoD* mutant strain, thanks to the reduction in the transcription rate. In addi-
tion, the cell altered protein expression patterns, as indicated in Table 1 and in more detail in Supplemental 
Table S1, to further alleviate the stress response. It is notable that all clones identified by selection for functional 
GPCR expression have mutations in rpoD, and among this strain collection, no other gene was found to improve 
GPCR expression.
Different genetic approaches to randomly mutate E. coli in order to obtain strains with improved mem-
brane protein overexpression characteristics have also ultimately led to a lowering of expression rates53–55. E. 
coli BL21(DE3) harbors a phage λDE3 lysogen that carries the gene for T7 RNA polymerase under control of 
the lacUV5 promoter. When membrane proteins were expressed in this system, they frequently showed signs 
of strong toxicity and most of the cells died. Selecting for survivors, the strains C41(DE3) and C43(DE3) were 
found53, which later on were identified to have accumulated “weakening” mutations in the lacUV5 promoter, 
leading to reduced synthesis of the T7 polymerase upon induction with IPTG54. Afterward, whole genome 
sequencing identified mutations in yehU (encoding a putative peptide transporter), rbsD::IS150 (the mutation 
is enabling efficient growth on ribose), and dcuS_ps (the mutation converts the pseudogene into an enzyme 
allowing efficient utilization of C4-dicarboxylates); however these additional mutations appear to have been the 
prerequisite for the lacUV5 promoter being able to mutate, rather than being directly linked to improved IMP 
overexpression56. In addition, mutant V192F of the lac repressor gene lacI binds more tightly to the lac-operator, 
and thus being a stronger repressor, improving overexpression to certain membrane proteins in C41(DE3)57. In 
a yet another approach, the strain Lemo(DE3) was constructed, where the gene encoding the T7 lysozyme, an 
inhibitor of T7-RNA polymerase, was placed under the control of the well titratable rhamnose promoter58. As 
additional example, another E. coli BL21(DE3) mutant was isolated, that contains point mutations in the gene 
encoding the T7 RNAP, lowering the affinity of the polymerase for the T7 promoter59. Both cases reduce T7 RNA 
polymerase mediated protein synthesis.
In the previous examples, the slower transcription rates of the target membrane protein comes from the 
decreased intracellular levels of the highly processive T7 RNA polymerase, which is thus reducing the amount of 
mRNA-template available for translation49. Therefore, those strain selections have addressed to some extent the 
same principle as in the present study, namely the reduction of synthesis rate (production per time unit) as one of 
the stress factors for IMP production. However, the rpoD mutations uncovered in the present work additionally 
alter the relative expression level of a number of genes that are related with stress as well as growth at low tem-
perature, since the rpoD * strains were found to grow for longer times under these conditions. Coexpression of 
some known bacterial components60,61 has also been investigated, and a transposon insertion library showed that 
deletion of a chaperone resulted in increased expression (albeit in an inactive form) of one GPCR62. Nonetheless, 
it seems that the dual action of the rpoD* mutation in altering the level of host genes, in conjunction with a slower 
expression rate of the GPCR, leads to the beneficial effects on GPCR expression and growth duration found in 
the present work.
Another example of an E. coli strain with improved membrane protein overexpression characteristics was 
isolated by Massey-Gendel and colleagues55, showing a reduced copy number of the overexpression vectors. In 
yet a different approach, a single nucleotide transversion in one of the CRP interaction domains of the pBAD 
arabinose promoter was isolated that reduces the transcription rates by about 70% and can improve the yields of 
some membrane proteins63.
In all these examples the unifying feature is the lowered expression rate that improves membrane protein over-
expression yields. In contrast, with the rpoD mutations found here, we achieved an additional fine tuning which 
was not entirely reached with the more traditional procedures of lowering expression only, being by promoter 
strength or plasmid copy number. Indeed, for the GPCRs studied here, it was found necessary, but not sufficient 
to decrease the translation rate by lowering the culture temperature or inducer concentration, or by choosing a 
weaker promoter. The global rpoD effect resulted in additional benefits due to the longer growth and thus expres-
sion duration of the bacterial cells.
Conclusions
While we initially started off from a single-gene deletion strategy in searching for strains with improved func-
tional GPCR expression properties, we found no single gene with these properties. Instead, our selection uncov-
ered subtle mutations in rpoD as the recurring motif in all mutant strains with the desired phenotype. The altered 
sigma factor 70 has an effect on the receptor expression itself, in that the rate of biosynthesis at 20 °C is lowered, 
but it continues for much longer, and cell growth is also continuing in parallel, resulting in a 4-fold higher final 
functional GPCR yield in the mutants rpoD* strain. Importantly, the rpoD mutations also affect the strain itself, as 
it grows to higher densities at 20 °C, even in the absence of GPCR expression, and this effect is more pronounced 
when it overcomes the growth inhibition due to stress in the presence of a GPCR. We found that the mutated 
sigma 70 alters the relative expression level of many genes, and thus also has a general effect on alleviating stress 
from the overexpression of the GPCR at several levels, contributing to the desirable phenotype.
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These findings can now be exploited in further strain engineering, as optimization of the expression of other 
membrane protein families or even other toxic soluble proteins may need a different optimized rpoD mutant. 
The development of expression strains with superior capability for heterologous functional membrane protein 
production may be particularly useful for isotope-labeled proteins as used in NMR for which E. coli is by far the 
most convenient expression system. Transcriptional factor fine-tuning may provide a different way of coordinate 
and well-adjust the biogenesis of membrane proteins.
Materials and Methods
Materials. Unless otherwise noted, chemicals were of the highest quality obtainable and purchased from 
Sigma or AppliChem. Enzymes for molecular biology were from New England Biolabs or Fermentas. All 
[3H]-labeled ligands were obtained from Perkin Elmer: [3,11-tyrosyl-3,5-3H(N)]-neurotensin (NT); [7-meth-
oxy-3H]-prazosin; 9-sar,11-met(O2)[2-prolyl-3,4-3H]-Substance-P and [tyrosyl-3,5-3H(N)]-[D-Ala2,N-Me-
Phe4,Gly-ol]-enkephalin (DAMGO) were purchased from Perkin-Elmer. All unlabeled ligands were purchased 
from AnaSpec. The fluorescent ligand HL647-NT(8–13) was obtained by custom synthesis from Anawa. (NT(8–
13) was labeled at the N-terminus with the fluorescent dye HiLyte Fluor 647 from AnaSpec.
Bacterial cultures. Bacterial cultures were grown in 2 × YT rich medium or, where indicated, in minimal 
medium: M9 salts, 1% (w/v) glucose, 0.5 mM thiamine hydrochloride, 10 mM MgSO4, 0.1 mM CaCl2 and a trace 
metal solution (Fe, Al, Mn, Co, Zn, Cu, and H3BO3).
Keio collection. The Keio collection is a systematically constructed library of E. coli mutants with 3985 pre-
cisely defined single-gene deletions representing all non-essential genes18. Each deleted target gene was replaced 
by a kanamycin resistance cassette19. The background genotype of the collection is the E. coli strain BW25113 
[Δ(araD-araB)567 ΔlacZ4787(::rrnB-3)−λ− rph-1 Δ(rhaD-rhaB)568 hsdR514]. The collection was obtained 
from the Nara Institute of Science and Technology, Keio University, Japan, and Purdue Research Foundation.
Protein expression. All GPCR variants were expressed as fusion proteins containing maltose binding pro-
tein (MBP) at the N-terminus and thioredoxin A (TrxA) at the C-terminus in a pBR322-derived vector denoted 
as pRG, as previously described8,10. Briefly, receptors were expressed in 2 × YT medium supplemented with 0.2% 
(w/v) glucose and 100 μg/ml ampicillin. The cells were grown at 37 °C until the culture reached OD600 = 0.5. At 
this cell density, protein expression was induced by addition of 250 μM IPTG and the cells were cultivated at 20 °C 
for 20 h.
FACS-based selections. FACS-based selections were performed as previously described10,11. Briefly, cells 
were permeabilized after receptor expression by washing with TKCl buffer (50 mM Tris-HCl, 150 mM KCl, pH 
7.4 at 4 °C). After permeabilization, binding of fluorescent ligand was performed in TKCl buffer supplemented 
with 80 nM HL647-NT (8–13) at 4 °C without exposure to light for 2 h. For measurement of the non-specific 
signal, competitive ligand binding was performed with the TKCl buffer containing, in addition to the fluorescent 
ligand, also 80 µM unlabeled NT(8–13). After ligand binding, cells were washed and resuspended in TKCL buffer 
and sorting was done on a BD FACS Aria I cell sorter (BD Biosciences). Sorted cells were collected in 2 × YT 
medium supplemented with 1% (w/v) glucose and 100 μg/ml ampicillin and grown overnight at 37 °C.
Inverse PCR. Genomic DNA (gDNA) from each clone to be analyzed was extracted from approximately 
5 × 109 E. coli cells with the GenElute™ Bacterial Genomic DNA Kit (Sigma-Aldrich, Cat. No. NA2110). 3 μg 
of genomic DNA were digested with 100 units of the restriction enzyme MseI (New England Biolabs) at 37 °C 
for 5 h. Due to its four-nucleotide recognition site, MseI cuts the genomic DNA frequently. However, there is 
no MseI site present within the kanamycin cassette, which replaces the deleted genes in the clones of the Keio 
collection. The digested DNA was purified with the QIAquick PCR purification kit (Qiagen, Cat. No. 28104). 
In order to promote intramolecular ligation of the genomic DNA fragments to give circular DNA, the digested 
DNA was diluted. For this purpose, approximately 75 ng of each digested DNA was used for a 100-μl ligation 
reaction. Ligation was performed with T4 DNA ligase (Thermo Fisher Scientific) at 16 °C for 18 h. Subsequently, 
the ligated DNA fragments were purified with the QIAquick PCR purification kit. The DNA fragment containing 
the kanamycin resistance cassette and parts of the adjacent DNA regions was then amplified in a PCR reac-
tion using Phusion High-Fidelity DNA polymerase (New England Biolabs) and outward primers annealing to 
the kanamycin resistance cassette (forward primer: 5′-TGCTTTACGGTATCGCCGCTCC-3′; reverse primer: 
5′-ACATTCATCCGGGGTCAGCACC-3′). The PCR product was then purified with the QIAquick PCR purifi-
cation kit and subsequently sent to sequencing, allowing the identification of the deleted gene by analysis of the 
DNA sequence adjacent to the kanamycin resistance cassette.
Radioligand-binding assays. Whole-cell radioligand-binding assays (RLBAs) in E. coli were performed as 
previously described12. The [3 H]-labeled ligands (NT, Prazosin, Substance-P and DAMGO) were used at 20 nM 
and competed with 20 μM unlabeled ligand to determine the non-specific signal.
Chromosomal gene deletions. The procedure to delete genes in the E. coli BW25513 chromosome was 
adapted from Datsenko and Wanner19 and Baba et al.18. To delete a gene in E. coli BL21, the Quick and Easy E. coli 
gene deletion kit using Red/ET recombination was used (Gene Bridges, Cat. No. K006).
Western blots. In order to load the same number of cells of each strain, E. coli whole cell protein extracts 
were obtained from 1 × 108 cells, as estimated by optical densities measured at 600 nm. These normalized 
numbers of cells were resuspended in 50 µl reducing NuPAGE LDS sample buffer (Life Technologies, Cat. No. 
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NP0008). Samples were incubated at 25 °C for 15 min with mixing, centrifuged, and 10 µL of each sample were 
run at 100 V for 3 h on a NuPAGE 4–12% Bis-Tris protein gel (Life Technologies, Cat. No. NP0335) in NuPAGE 
MES SDS running buffer (Life Technologies, Cat. No. NP0002) supplemented with NuPAGE sample reducing 
agent (Life Technologies, Cat. No. NP0004) and NuPAGE antioxidant (Life Technologies, Cat. No. NP0005). 
Proteins were transferred to Immobilon PVDF-FL membranes (Merck Millipore, Cat. No. PFL00010) activated 
in methanol by using a Trans-Blot® SD Semi-Dry Transfer Cell (Bio-Rad) at 10 V for 1 h. Blocking of membranes 
was performed in 1 × casein blocking buffer (Sigma-Aldrich, Cat. No. C7594) in PBS at RT for 20 min. Antibody 
binding was performed in 1 × casein blocking buffer in PBST (PBS, 0.1% (v/v) Tween-20) at RT for 1 h, and 
PBST was used for all membrane washing steps. Primary mouse anti-MBP antibody was used at a dilution of 
1:4,000 and the secondary antibody alkaline phosphatase anti mouse IgG at a dilution of 1:10,000. Detection was 
achieved with NBT-BCIP (ThermoFischer, Cat. No. 34042) in detection buffer (100 mM Tris-HCl, 100 mM NaCl, 
5 mM MgCl2, pH 9.5 at 25 °C).
Whole genome sequencing. Sequencing of whole genome was carried out both with PacBio RSII and 
Illumina MiSeq. The methods are described in detail in the Supplementary Methods.
Site-directed mutagenesis in the E. coli genome. This was carried combining the method of 
Datsenko and Wanner for gene deletions19 with Splicing by Overlap Extension64, and is described in detail in the 
Supplementary Methods.
RNA-sequencing. Sample preparation was done with the TruSeq RNA Sample Prep kit v2 with 
ribosomal-RNA-depleted total RNA samples. RNA sequencing was done with the TruSeq SR Cluster Kit 
v4-cBot-HS. Details on sample preparation and methods are explained in the Supplementary Methods.
Bioinformatics. The software packages and methods used are described in detail in the Supplementary 
Methods.
Quantitative real time PCR. Quantitative PCR was performed following the MIQE guidelines and using a 
Mx3005P qPCR System. Sample preparation details and evaluation are explained in the Supplementary Methods.
Data Availability
All data generated and analyzed during this study are included in this published article (and its Supplementary 
Information files). The RNA sequencing reads and raw counts have been deposited in Gene Expression Omnibus 
of NCBI under accession number GSE109819.
References
 1. Almén, M., Nordström, K. J., Fredriksson, R. & Schiöth, H. B. Mapping the human membrane proteome: a majority of the human 
membrane proteins can be classified according to function and evolutionary origin. BMC Biol. 7, 50 (2009).
 2. Carpenter, E. P., Beis, K., Cameron, A. D. & Iwata, S. Overcoming the challenges of membrane protein crystallography. Curr. Opin. 
Struct. Biol. 18, 581–586 (2008).
 3. Cherezov, V., Abola, E. & Stevens, R. C. Recent progress in the structure determination of GPCRs, a membrane protein family with 
high potential as pharmaceutical targets. Methods Mol. Biol. 654, 141–168 (2010).
 4. Wagner, S., Bader, M. L., Drew, D. & de Gier, J.-W. Rationalizing membrane protein overexpression. Trends Biotechnol. 24, 364–371 
(2006).
 5. Schlegel, S. et al. Revolutionizing membrane protein overexpression in bacteria. Microb. Biotechnol. 3, 403–411 (2010).
 6. Wang, D.-N. et al. Practical aspects of overexpressing bacterial secondary membrane transporters for structural studies. Biochim. 
Biophys. Acta (BBA) - Biomembranes 1610, 23–36 (2003).
 7. Gardner, K. H. & Kay, L. E. The use of 2H, 13C, 15N multidimensional NMR to study the structure and dynamics of proteins. Annu. 
Rev. Biophys. Biomol. Struct. 27, 357–406 (1998).
 8. Tucker, J. & Grisshammer, R. Purification of a rat neurotensin receptor expressed in Escherichia coli. Biochem. J. 317, 891–899 
(1996).
 9. Martinez Molina, D. et al. Engineering membrane protein overproduction in Escherichia coli. Protein Sci. 17, 673–680 (2008).
 10. Sarkar, C. A. et al. Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity. Proc. Natl. 
Acad. Sci. USA 105, 14808–14813 (2008).
 11. Dodevski, I. & Plückthun, A. Evolution of three human GPCRs for higher expression and stability. J. Mol. Biol. 408, 599–615 (2011).
 12. Schlinkmann, K. M. et al. Maximizing detergent stability and functional expression of a GPCR by exhaustive recombination and 
evolution. J. Mol. Biol. 422, 414–428 (2012).
 13. Schlinkmann, K. M. et al. Critical features for biosynthesis, stability, and functionality of a G protein-coupled receptor uncovered by 
all-versus-all mutations. Proc. Natl. Acad. Sci. USA 109, 9810–9815 (2012).
 14. Schütz, M. et al. Directed evolution of G protein-coupled receptors in yeast for higher functional production in eukaryotic 
expression hosts. Sci. Rep. 6, 21508 (2016).
 15. Freigassner, M., Pichler, H. & Glieder, A. Tuning microbial hosts for membrane protein production. Microb. Cell Fact. 8, 69 (2009).
 16. Makrides, S. C. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. 60, 512–538 (1996).
 17. Grisshammer, R. Understanding recombinant expression of membrane proteins. Curr. Opin. Biotechnol. 17, 337–340 (2006).
 18. Baba, T. et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2, 
1–11 (2006).
 19. Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. 
Natl. Acad. Sci. USA 97, 6640–6645 (2000).
 20. Grenier, F., Matteau, D., Baby, V. & Rodrigue, S. Complete genome sequence of Escherichia coli BW25113. Genome Announc. 2, 
e01038–14 (2014).
 21. Gruber, T. M. & Gross, C. A. Multiple sigma subunits and the partitioning of bacterial transcription space. Annu. Rev. Microbiol. 57, 
441–466 (2003).
 22. Lonetto, M. A. E. A., Gribskov, M. & Gross, C. A. The sigma 70 family: sequence conservation and evolutionary relationships. J. 
Bacteriol. 174, 3843–3839 (1992).
13Scientific RepoRts |          (2019) 9:2483  | https://doi.org/10.1038/s41598-019-39492-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
 23. Ukkonen, K., Vasala, A., Ojamo, H. & Neubauer, P. High-yield production of biologically active recombinant protein in shake flask 
culture by combination of enzyme-based glucose delivery and increased oxygen transfer. Microb. Cell Fact. 10, 107 (2011).
 24. Egloff, P. et al. Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli. Proc. Natl. 
Acad. Sci. USA 111, E655–62 (2014).
 25. Aguilar, C. et al. Genetic changes during a laboratory adaptive evolution process that allowed fast growth in glucose to an Escherichia 
coli strain lacking the major glucose transport system. BMC Genomics 13, 385 (2012).
 26. Zhou, K. et al. Novel reference genes for quantifying transcriptional responses of Escherichia coli to protein overexpression by 
quantitative PCR. BMC Mol. Biol. 12, 18 (2011).
 27. Hruz, T. et al. RefGenes: identification of reliable and condition specific reference genes for RT-qPCR data normalization. BMC 
Genomics 12, 156 (2011).
 28. Devonshire, A. S., Elaswarapu, R. & Foy, C. A. Evaluation of external RNA controls for the standardisation of gene expression 
biomarker measurements. BMC Genomics 11, 662 (2010).
 29. Valent, Q. A. et al. The Escherichia coli SRP and SecB targeting pathways converge at the translocon. EMBO J. 17, 2504–2512 (1998).
 30. Luirink, J., Yu, Z., Wagner, S. & de Gier, J.-W. Biogenesis of inner membrane proteins in Escherichia coli. Biochim. Biophys. Acta 
(BBA) - Bioenergetics 1817, 965–976 (2012).
 31. Wagner, S. et al. Consequences of membrane protein overexpression in Escherichia coli. Mol. Cell Proteomics 6, 1527–1550 (2007).
 32. Lee, H., Popodi, E., Tang, H. & Foster, P. L. Rate and molecular spectrum of spontaneous mutations in the bacterium Escherichia coli 
as determined by whole-genome sequencing. Proc. Natl. Acad. Sci. USA 109, E2774–83 (2012).
 33. Maharjan, R. & Ferenci, T. Mutational signatures indicative of environmental stress in bacteria. Mol. Biol. Evol. 32, 380–391 (2015).
 34. Zhou, J. & Rudd, K. E. EcoGene 3.0. Nucleic Acids Res. 41, D613–D624 (2013).
 35. Jishage, M., Iwata, A., Ueda, S. & Ishihama, A. Regulation of RNA polymerase sigma subunit synthesis in Escherichia coli: 
intracellular levels of four species of sigma subunit under various growth conditions. J. Bacteriol. 178, 5447–5451 (1996).
 36. Maeda, H., Fujita, N. & Ishihama, A. Competition among seven Escherichia coli σ subunits: relative binding affinities to the core 
RNA polymerase. Nucleic Acids Res. 28, 3497–3503 (2000).
 37. Chou, C. P. Engineering cell physiology to enhance recombinant protein production in Escherichia coli. Appl. Microbiol. Biotechnol. 
76, 521–532 (2007).
 38. Murakami, K. S. X-ray Crystal structure of Escherichia coli RNA polymerase 70 holoenzyme. J. Biol. Chem. 288, 9126–9134 (2013).
 39. Zuo, Y. & Steitz, T. A. Crystal structures of the E. coli transcription initiation complexes with a complete bubble. Molecular Cell 58, 
534–540 (2015).
 40. Jishage, M., Kvint, K., Shingler, V. & Nyström, T. Regulation of sigma factor competition by the alarmone ppGpp. Genes & 
Development 16, 1260–1270 (2002).
 41. Landini, P., Bown, J. A., Volkert, M. R. & Busby, S. J. W. Ada protein-RNA polymerase σ subunit interaction and α subunit-promoter 
DNA interaction are necessary at different steps in transcription initiation at the Escherichia coli ada and aidB Promoters. J. Biol. 
Chem. 273, 13307–13312 (1998).
 42. Olekhnovich, I. N. & Kadner, R. J. RNA polymerase α and σ70 subunits participate in transcription of the Escherichia coli uhpT 
promoter. J. Bacteriol. 181, 7266–7273 (1999).
 43. Hu, J. C. & Gross, C. A. Mutations in rpoD that increase expression of genes in the mal regulon of Escherichia coli K-12. J. Mol. Biol. 
203, 15–27 (1988).
 44. Siegele, D. A., Hu, J. C. & Gross, C. A. Mutations in rpoD, the gene encoding the sigma 70 subunit of Escherichia coli RNA 
polymerase, that increase expression of the lac operon in the absence of CAP-cAMP. J. Mol. Biol. 203, 29–37 (1988).
 45. Makino, K., Amemura, M., Kim, S. K., Nakata, A. & Shinagawa, H. Role of the sigma 70 subunit of RNA polymerase in 
transcriptional activation by activator protein PhoB in Escherichia coli. Genes & Development 7, 149–160 (1993).
 46. Siegele, D. A., Hu, J. C., Walter, W. A. & Gross, C. A. Altered promoter recognition by mutant forms of the sigma 70 subunit of 
Escherichia coli RNA polymerase. J. Mol. Biol. 206, 591–603 (1989).
 47. Tan, F.-R. et al. Improving furfural tolerance of Zymomonas mobilis by rewiring a sigma factor RpoD protein. Appl. Microbiol. 
Biotechnol. 99, 5363–5371 (2015).
 48. Chou, H.-H., Marx, C. J. & Sauer, U. Transhydrogenase promotes the robustness and evolvability of E. coli deficient in NADPH 
production. PLoS Genet. 11, e1005007–26 (2015).
 49. Klepsch, M. M., Persson, J. O. & de Gier, J.-W. L. Consequences of the overexpression of a eukaryotic membrane protein, the human 
KDEL receptor, in Escherichia coli. J. Mol. Biol. 407, 532–542 (2011).
 50. Xu, L. Y. & Link, A. J. Stress responses to heterologous membrane protein expression in Escherichia coli. Biotechnol. Lett. 31, 
1775–1782 (2009).
 51. Barria, C., Malecki, M. & Arraiano, C. M. Bacterial adaptation to cold. Microbiology 159, 2437–2443 (2013).
 52. White-Ziegler, C. A. et al. Low temperature (23 degrees C) increases expression of biofilm-, cold-shock- and RpoS-dependent genes 
in Escherichia coli K-12. Microbiology 154, 148–166 (2008).
 53. Miroux, B. & Walker, J. E. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane 
proteins and globular proteins at high levels. J. Mol. Biol . 260, 289–298 (1996).
 54. Wagner, S. et al. Tuning Escherichia coli for membrane protein overexpression. Proc. Natl. Acad. Sci. USA 105, 14371–14376 (2008).
 55. Massey-Gendel, E. et al. Genetic selection system for improving recombinant membrane protein expression in E. coli. Protein Sci. 
18, 372–383 (2009).
 56. Schlegel, S., Genevaux, P. & de Gier, J.-W. De-convoluting the genetic adaptations of E. coli C41(DE3) in real time reveals how 
alleviating protein production stress improves yields. Cell Rep. 10, 1758–1766 (2015).
 57. Kwon, S.-K., Kim, S. K., Lee, D.-H. & Kim, J. F. Comparative genomics and experimental evolution of Escherichia coli BL21(DE3) 
strains reveal the landscape of toxicity escape from membrane protein overproduction. Sci. Rep. 5, 16076 (2015).
 58. Schlegel, S. et al. Optimizing membrane protein overexpression in the Escherichia coli strain Lemo21(DE3). J. Mol. Biol. 423, 
648–659 (2012).
 59. Baumgarten, T. et al. Isolation and characterization of the E. coli membrane protein production strain Mutant56(DE3). Sci. Rep. 7, 
45089 (2017).
 60. Link, A. J., Skretas, G., Strauch, E.-M., Chari, N. S. & Georgiou, G. Efficient production of membrane-integrated and detergent-
soluble G protein-coupled receptors in Escherichia coli. Protein Sci. 17, 1857–1863 (2008).
 61. Skretas, G. & Georgiou, G. Simple genetic selection protocol for isolation of overexpressed genes that enhance accumulation of 
membrane-integrated human g protein-coupled receptors in Escherichia coli. Appl. Environ. Microbiol. 76, 5852–5859 (2010).
 62. Skretas, G. & Georgiou, G. Genetic analysis of G protein-coupled receptor expression in Escherichia coli: Inhibitory role of DnaJ on 
the membrane integration of the human central cannabinoid receptor. Biotechnol. Bioeng. 102, 357–367 (2009).
 63. Nannenga, B. L. & Baneyx, F. Enhanced expression of membrane proteins in E. coli with a P(BAD) promoter mutant: synergies with 
chaperone pathway engineering strategies. Microb. Cell Fact. 10, 105 (2011).
 64. Horton, R. M. et al. Gene splicing by overlap extension. Meth. Enzymol. 217, 270–279 (1993).
 65. Paget, M. Bacterial sigma factors and anti-sigma factors: structure, function and distribution. Biomolecules 5, 1245–1265 (2015).
1 4Scientific RepoRts |          (2019) 9:2483  | https://doi.org/10.1038/s41598-019-39492-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
Acknowledgements
P.E.T. was supported by a fellowship of the Novartis Foundation and a Marie Curie fellowship of the European 
Commission (FP7-PEOPLE-2011-IIF #298592, Project Acronym: BioIMPrOve). This work was funded by 
European Research Council Advanced Grant NEXTBINDERS and Schweizerischer Nationalfonds grant 
31003A_146278 (both to A.P.). The authors acknowledge the source of the KEIO collection to Nara Institute of 
Science and Technology, Keio University and Purdue Research Foundation. We would like to thank Malgorzata 
Kisielow and Anette Schütz of the Flow Cytometry Laboratory of the Institute for Biomedical Engineering, 
University of Zurich and ETH Zurich for their professional help and assistance with FACS. Also, we thank 
Annemarie Honegger for graphical design of Fig. 2. Furthermore, we would like to thank Igor Dodevski, Karola 
M. Schlinkmann and Christoph Klenk for their input and helpful discussions.
Author Contributions
P.E.T. and A.P. designed the research. P.E.T., E.U. and M.S. performed experiments and analyzed data. P.E.T. and 
A.P. wrote the manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-019-39492-9.
Competing Interests: The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
